Pathology Doctors in W. Reading, PA Accepting Medicare
2 Pathology doctors found. Showing 1 - 2
 William Natale, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 6th Ave And Spruce St, W. Reading, PA 19611 Phone: 610-988-8615 |
William Kimmel, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 6th Ave And Spruce St, W. Reading, PA 19611 Phone: 610-988-8615 |
News Archive
Strengthening the tumor-fighting ability of T cells
When faced with cancer, the immune system dispatches cells, called T cells, to kill the tumor.
European Commission releases two new Patient Blood Management guides
On April 3, 2017 the European Commission published two guides on the implementation of Patient Blood Management; one addressed to national authorities and the other to hospitals.
Lixte, NCI collaborate for clinical evaluation of LB-100 compound
Lixte Biotechnology Holdings announced today that the National Cancer Institute Experimental Therapeutics (NExT) Program Senior Advisory Committee (SAC), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institutes of Health (NIH), signed a NExT Material Transfer Agreement formalizing a collaboration with Lixte Biotechnology Holdings, Inc. for clinical evaluation of LB-100, one of Lixte's lead anti-cancer compounds.
Rotavirus vaccination not linked to type 1 diabetes mellitus risk
Rotavirus infection is thought to be a risk factor for type 1 diabetes mellitus (T1DM). The role played by live attenuated rotavirus vaccination in the risk of this condition in children is, therefore, an area of active research. A new study published in the journal JAMA Pediatrics in March 2020 debunks this concern.
Abbott seeks U.S. approval for HE4 assay to monitor recurrence/progression of epithelial ovarian cancer
A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States. Abbott's ARCHITECT HE4 assay uses a simple blood test to help in monitoring for the recurrence or progression of epithelial ovarian cancer. If approved, this important immunoassay would be the first automated HE4 test available in the United States.
› Verified 6 days ago
Internal Medicine
Pathology
Emergency Medicine
Obstetrics & Gynecology